A statement on Novo Nordisks website says its deeply concerned about companies promoting and selling compounded, non-FDA-approved, or knock-off semaglutide and sources spreading misinformation about GLP-1s to the public. Navigate the healthcare industry Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed
Interestingly, certain bitter compounds, such as denatonium benzoate (DB), have been found to stimulate the secretion of insulin, glucagon, somatostatin, and GLP-1 from pancreatic islets independently of glucose levels
To reduce risks, educate patients on safe injection methods, site rotation, and sharps disposal
If you're in Colorado Springs and your previous provider has prescribed Ozempic off-label for weight loss, switching to a fully FDA-approved weight loss option can enhance insurance approval chances and ensure safer, standardized care